Skip to main content
Clinical Trials/EUCTR2017-002443-15-GB
EUCTR2017-002443-15-GB
Active, not recruiting
Phase 1

Improving cardiac function in high-risk surgical patients: exercise testing, biomarkers and beta-blockade - ICAF - BETA

York Teaching Hospitals NHS Foundation Trust0 sites44 target enrollmentSeptember 1, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
York Teaching Hospitals NHS Foundation Trust
Enrollment
44
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2017
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
York Teaching Hospitals NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • \- Aged 55 years or over
  • \- Scheduled for major intra\-abdominal surgery
  • \- Presenting for routine CPET as part of pre\-assessment
  • \- Not currently taking any BB medication and not taken BB medication within 1 month prior
  • \- Consent to GP being informed
  • \- VE/VCO2 greater than 34 on CPET, as either the value measured at VO2@AT, or the lowest measured value, plus at least one of the following:
  • \- Presence of a known history of a clinical risk factor for major adverse cardiac events (MACE) after surgery
  • ?Ischaemic heart disease
  • ?Cerebrovascular disease
  • ?Renal insufficiency (creatinine \> 170 ?mol.L\-1\)

Exclusion Criteria

  • \- Refusal or unable to give informed consent
  • \- Fewer than 7 days before scheduled surgery at pre\-assessment appointment surgery
  • \- Current Beta blocker medication or having taken any Beta blocker within 1 month prior
  • \- Contra\-indications to BB medication including:
  • obronchial asthma
  • oreversible airways disease
  • odecompensated heart failure (NYHA class IV)
  • ofluid overloaded
  • ohypotensive
  • osevere liver impairment

Outcomes

Primary Outcomes

Not specified

Similar Trials